ASCO Daily News

134 Episodo

1. Day 4: Top Takeaways From ASCO24

   Publicado: 3/6/2024
2. Day 3: Top Takeaways From ASCO24    

   Publicado: 2/6/2024
3. Day 2: Top Takeaways From ASCO24

   Publicado: 1/6/2024
4. Day 1: Top Takeaways From ASCO24  

   Publicado: 31/5/2024
5. Exploring CAR T Cells in GI Cancers at ASCO24

   Publicado: 25/5/2024
6. Key Abstracts in GU Cancers at ASCO24

   Publicado: 25/5/2024
7. ASCO24: The Future of Personalized Immunotherapy

   Publicado: 24/5/2024
8. Novel Approaches in Hematologic Malignancies at ASCO24

   Publicado: 24/5/2024
9. Spotlight on Breast Cancer at ASCO24

   Publicado: 23/5/2024
10. ASCO24: The Era of the ADCs in NSCLC

    Publicado: 23/5/2024
11. Optimizing Novel Therapies and Surgery in Early-Stage NSCLC

    Publicado: 25/4/2024
12. A Revolution in Immunotherapy for Cervical and Endometrial Cancers

    Publicado: 18/4/2024
13. How ctDNA Is Advancing Care for Patients With GI Cancers

    Publicado: 4/4/2024
14. New Machine Learning Framework Uses EHR Data to Assess ICI Effectiveness, Toxicity

    Publicado: 21/3/2024
15. Innovations in CAR T-Cell Therapy for Multiple Myeloma

    Publicado: 7/3/2024
16. ADCs in Breast Cancer: Sequencing, Resistance, and Managing Toxicity

    Publicado: 15/2/2024
17. Advances in Precision Oncology for GI Cancers at GI24

    Publicado: 8/2/2024
18. Key Advances in Prostate, Kidney, and Bladder Cancers at GU24

    Publicado: 6/2/2024
19. What’s New in Prostate Cancer, RCC, and mUC at GU24

    Publicado: 22/1/2024
20. Celebrating 20 Years of Evolution in GU Oncology

    Publicado: 14/12/2023